Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Tuesday newspaper round-up: Energy bills, Twitter, GSK

(Sharecast News) - The chief executive of National Grid has warned of an "exponential increase" in customers seeking help with their energy bills as the company created a £50m emergency support fund. John Pettigrew said the UK electricity network operator's fund will be used this winter and next to make donations to bodies providing support for vulnerable households and advice on energy efficiency measures to lower bills long term. - Guardian Elon Musk has appointed himself CEO of Twitter and dissolved its board of directors, it was revealed in a company filing on Monday, as Twitter employees brace for extensive layoffs under a new restructuring that could target up to a quarter of staff. The Washington Post reported on Monday that Musk's team has been discussing letting go of 25% of the company's workforce in a first round of layoffs. - Guardian

Rishi Sunak is drawing up plans for years of tax rises for everyone in the country, as a Treasury source warned: "It's going to be rough." On Monday, the Prime Minister and the Chancellor decided to bring in "stealth" increases in income tax and National Insurance over the coming years by freezing the thresholds at which people start to pay different rates. - Telegraph

More than 50 company directors who have been disqualified have faced no disciplinary action from the Financial Conduct Authority and seven remain approved by the regulator, a Times investigation has found. The findings underscore the failings of the watchdog's register, which keeps track of firms and individuals approved for regulated activities. The Times has uncovered at least 55 directors who were banned for offences ranging from pension fraud to tax evasion, while carrying out a role regulated by the authority. - The Times

About £40 million is likely to be set aside by GSK for legal costs relating to the Zantac litigation that has overshadowed the demerger of Haleon, its consumer healthcare wing, and has taken billions of pounds off the two companies' market values. The drugs group is expected to make a provision when it announces third-quarter figures tomorrow, covering its likely maximum defence costs in any legal action over the heartburn drug. GSK is being represented by Dechert, the law firm. - The Times

Share this article

Related Sharecast Articles

Thursday newspaper round-up: Thames Water, mortgage costs, UK car production
(Sharecast News) - Thames Water has breached its licence to supply water to nearly 16 million people after some of its debt was downgraded to junk status. The regulator Ofwat could now fine Thames, the country's largest water monopoly, up to 10% of its annual turnover, equating to hundreds of millions of pounds. However, since the company is already teetering close to temporary renationalisation, Ofwat is likely to hold off on any immediate large fines. - Guardian
Wednesday newspaper round-up: Reckitt, Tesla, Virgin Atlantic...
(Sharecast News) - Reckitt is under pressure from top shareholders to revisit a sale of its nutrition business, following litigation and a series of other setbacks at the division that have sent the company's share price to decade lows. The FTSE 100 consumer giant acquired the Mead Johnson infant formula business in 2017 for $17bn - its largest-ever acquisition - and it has been plagued by mishaps ever since. Meanwhile, the wider group, which makes Lysol detergent and Durex condoms, has underwhelmed investors as it struggles to build back sales volumes following a period of high inflation and suppressed consumer demand. - Financial Times
Tuesday newspaper round-up: Kamala Harris, Crowdstrike, Vivendi...
(Sharecast News) - Kamala Harris has secured enough delegates from her party to clinch the Democratic presidential nomination, as she pledged to offer Americans a "brighter future" compared to the "chaos, fear and hate" proposed by Donald Trump. The US vice-president was speaking in Wilmington, Delaware, on Monday, the first full day since President Joe Biden dropped his re-election bid and endorsed her for the Democratic presidential nomination, shaking up the 2024 race for the White House. - Financial Times
Monday newspaper round-up: Biden, gambling levy, UK economy...
(Sharecast News) - Kamala Harris, the vice-president, has emerged as the frontrunner to replace President Biden as the Democratic nominee for the election against Donald Trump in November. Biden, 81, announced yesterday afternoon that he would drop out of the race. In the hours that followed, Harris, 59, was endorsed by leading Democrats, prospective rivals and the chairs of all 50 state parties. - The Times

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.